Remimazolam as the Primary Agent for Sedation During Cardiac ...

In summary, remimazolam is an ultra-short-acting benzodiazepine that was approved by the FDA in 2020 for procedural sedation in adults. Clinical trials have ...

General anesthesia or procedural sedation may be required to ensure immobility, facilitate completion of the procedure, and ensure patient ...

Preliminary Experience With Remimazolam for Procedural Sedation ...

Preliminary experience in adults has demonstrated remimazolam to be an effective and safe agent for procedural sedation during upper and lower ...

Remimazolam in Cardiac Anesthesia: Analysis of Recent Data

Remimazolam represents a promising advance in the realm of cardiovascular anesthesia and procedural sedation. This review highlights the unique ...

Remimazolam-flumazenil provides fast recovery from general ...

Propofol is commonly used as the primary anesthetic agent during cardiac catheterization and electrophysiology suites. Although it induces ...

Remimazolam as the Primary Agent for Sedation During Cardiac ...

Remimazolam, a novel ester-metabolized benzodiazepine, was used as the primary agent for sedation in an effort to limit detrimental effects ...

Remimazolam in Focus: Enhancing Anesthesia, Managing Risks

Ideal intravenous anesthetic agent ... The primary contender as a superior hypnotic is remimazolam (Byfavo®), a benzodiazepine developed by PAION AG and granted ...

Remimazolam as a Primary Agent for Brief Invasive and ...

Remimazolam is a novel benzodiazepine with sedative and amnestic properties similar to midazolam. Ester metabolism results in a half-life of 5 - ...

The Emerging Role of Remimazolam in Cardiac Anesthesia

Share ; Kalsotra et al. · 8. Kalsotra, S ∙ Khan, S ∙ McKee, C ... Remimazolam as the primary agent for sedation during cardiac catheterization in ...

A comprehensive review of remimazolam for sedation

Remimazolam has presented a favorable alternative to some of the common intravenous anesthetic agents used given its fast onset of action, high safety profile,

The Emerging Role of Remimazolam in Cardiac Anesthesia

Remimazolam as the primary agent for sedation during cardiac catheterization in three patients with comorbid cardiac conduction abnormalities.

Remimazolam and Its Place in the Current Landscape of Procedural ...

Remimazolam is mainly tested in procedural sedation. In comparison to propofol, the current gold standard for procedural sedation, its proposed attractiveness ...

Remimazolam: Non-Clinical and Clinical Profile of a New Sedative ...

It is differentiated from other intravenous hypnotic agents, such as propofol, by its low liability for cardiovascular depression, respiratory ...

Exploring Remimazolam: Enhancing Procedural Sedation and ...

Remimazolam served as the primary sedative in 82% of the cases. Most instances (25 sessions, 76%) involved administering a bolus dose of ...

Remimazolam in General Anesthesia: A Comprehensive Review of ...

Clinical trials have demonstrated its efficacy in procedural sedation and general anesthesia, showing a favorable safety profile with minimal ...

Remimazolam for cardiovascular anesthesia

Remimazolam, a novel benzodiazepine, has been widely used for general anesthesia in Japan since 2020. Initial clinical trials for general ...

Remimazolam for Sedation During Fiberoptic Intubation in an ...

Preliminary clinical experience in adults has demonstrated its efficacy as a primary agent for procedural sedation, as the primary agent to ...

Preliminary Experience With Remimazolam for Procedural Sedation ...

The most common procedures were endomyocardial biopsy or isolated hemodynamic assessment (right or left heart catheterization). Remimazolam was ...

Remimazolam as an Adjunct to General Anesthesia During Spine ...

Preliminary clinical experience has demonstrated its efficacy in the adult population as a primary agent for procedural sedation or as an ...

Hemodynamic Influences of Remimazolam Versus

Remimazolam may be ben- eficial as a main drug for procedural sedation with a native airway in the cardiac catheterization suite. Some data suggest that it has ...